Valeant ‘substantially undervalues’ Allergan
May 13, 2014Sales and Marketing Allergan, Botox, Pfizer, Valeant, buyout, merger
Allergan’s board has issued a defiant, unanimous rejection of the multi-billion dollar takeover offer made public by Valeant last month. In …
Ranbaxy woes hit profits
May 13, 2014Manufacturing and Production, Sales and Marketing Q1, Ranbaxy, Sun Pharma, manufacturing, recall
Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …
Biotec hires non-executive director
May 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, ashley cooper
Logistics services firm Biotec Services International has expanded its board with the appointment of a non-executive director. Joining the UK-headquartered …
Poll: UK opposed to Pfizer takeover bid of AZ
May 13, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, buyout, merger, research
The UK’s largest union says a new poll shows that the vast majority of the British public are against Pfizer’s …
SHL to attend the 2014 PDA Japan: A collaborative approach to developing combination products
May 13, 2014Medical Communications auto injector, autoinjectors, pda japan 2014, pen injector, shl pda 2014
Tokyo, Japan – SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that …
‘Star Wars’ robot arm approved by FDA
May 12, 2014Manufacturing and Production, Medical Communications, Sales and Marketing FDA, arm, deka arm system, luke, star wars
The FDA has approved a first of its kind robotic arm that can be used to make complex tasks far …
Boehringer launches new transparency regime
May 12, 2014Research and Development, Sales and Marketing Boehringer, LEO Pharma, all trials, csr, transparency
Boehringer is making good on its 2013 promise to release more clinical trial data to researchers with the launch of …
AZ ‘consulted first’ by UK government after Pfizer bid
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, George Osborne, Pfizer, Wellcome Trust, david cameron
UK prime minister David Cameron has rejected claims that his government is prioritising discussions with Pfizer over its proposed acquisition …
Pfizer signs universities deal
May 12, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, academics, rare diseases
Pfizer has signed a five-year research deal with several top British universities to hunt for new treatments for rare disease. …
‘Bioscience is cornerstone’ of Alderley Park
May 12, 2014Research and Development, Sales and Marketing AZ, AstraZeneca, alderley, msp, research
Manchester Science Parks (MSP), the new owners of the 400-acre Alderley Park facility, has pledged to keep its activities “at …
Lundbeck buys Chelsea Therapeutics
May 12, 2014Research and Development, Sales and Marketing Chelsea Therapeutics, Lundbeck
Lundbeck could pay as much as $658 million for neurological disorder specialist Chelsea Therapeutics as the firm looks to shore …
Clinical trials transparency: the journey so far
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency
There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …
Talentmark hires Benelux executive search head
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Talentmark, lebbink
Life sciences recruitment firm Talentmark has confirmed Christiaan Lebbink is to join the firm covering the Benelux and continental European region Lebbink, …
Merck’s vorapaxar gains long-awaited FDA approval
May 9, 2014Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity
Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …
AstraZeneca begins lung cancer trial
May 9, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, MEDI4736, NSCLC, lung cancer
AstraZeneca, currently at the centre of a £63 billion bid from US giant Pfizer, has begun a late-stage trial of …
Wellcome Trust slams Pfizer/AstraZeneca bid
May 9, 2014Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover
The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …
Latest Sun Pharma recall blow for firm
May 9, 2014Manufacturing and Production Caraco, Cetirizine, Effexor, FDA, Sun Pharma, recall
India’s largest drugmaker Sun Pharmaceutical Industries is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the US, because …
ABPI appoints manager 
from Pfizer

May 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pfizer, christine rowland
The ABPI has appointed Christine Rowland to the newly-created position of value and access manager for its commercial department. Rowland …
NICE recommends Xtandi
May 9, 2014Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate
NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …
EU looks at eye drug allegations
May 8, 2014Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel
European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
